INTEGRATION BETWEEN METABOLIC TUMOUR VOLUME AND METABOLIC HETEROGENEITY PREDICTS OUTCOME OF DLBCL LYMPHOMA PATIENTS IN THE SAKK 38/07 STUDY COHORT. (12th June 2019) - Ceriani, L.; Pirosa, M.; Stathis, A.; Gritti, G.; Ruberto, T.; Bruno, A.; Moccia, A.; Rambaldi, A.; Ferrari, S.; Giovannella, L.; Hayoz, S.; Mazzucchelli, L.; et al.